UA91733C2 - Способ получения кристаллической формы орлистата - Google Patents

Способ получения кристаллической формы орлистата

Info

Publication number
UA91733C2
UA91733C2 UAA200809715A UAA200809715A UA91733C2 UA 91733 C2 UA91733 C2 UA 91733C2 UA A200809715 A UAA200809715 A UA A200809715A UA A200809715 A UAA200809715 A UA A200809715A UA 91733 C2 UA91733 C2 UA 91733C2
Authority
UA
Ukraine
Prior art keywords
orlistat
crystalline forms
preparing crystalline
preparing
crystalline form
Prior art date
Application number
UAA200809715A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ігор Сімоніц
Прімоз Бенкіц
Анамарія Вайс
Андрейка Крамар
Антон Стімац
Original Assignee
Крка Товарна Здравіл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36354129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA91733(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Крка Товарна Здравіл filed Critical Крка Товарна Здравіл
Publication of UA91733C2 publication Critical patent/UA91733C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Данное изобретение относится к способу получения кристаллических форм орлистата, в частности, орлистата кристаллической формы II, как описано в WO 2005/026140.
UAA200809715A 2005-12-27 2006-12-27 Способ получения кристаллической формы орлистата UA91733C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05028489A EP1803714A1 (en) 2005-12-27 2005-12-27 Process for preparing crystalline forms of orlistat
PCT/EP2006/012544 WO2007073937A2 (en) 2005-12-27 2006-12-27 Process for preparing crystalline forms of orlistat

Publications (1)

Publication Number Publication Date
UA91733C2 true UA91733C2 (ru) 2010-08-25

Family

ID=36354129

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200809715A UA91733C2 (ru) 2005-12-27 2006-12-27 Способ получения кристаллической формы орлистата

Country Status (5)

Country Link
EP (2) EP1803714A1 (ru)
EA (1) EA015940B1 (ru)
NO (1) NO20083269L (ru)
UA (1) UA91733C2 (ru)
WO (1) WO2007073937A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat
PL2002825T3 (pl) * 2007-06-14 2013-12-31 Krka Kompozycje farmaceutyczne zawierające orlistat
WO2009040827A1 (en) * 2007-09-24 2009-04-02 Biocon Limited A process for obtaining tetrahydrolipstatin
EP2141236A1 (en) 2008-07-03 2010-01-06 KRKA, D.D., Novo Mesto Process for production of lipstatin and microorganisms therefore
US20120022274A1 (en) * 2009-01-22 2012-01-26 Umesh Sannachikkanna Crystalline Form of Orlistat and a Process Thereof
KR102679975B1 (ko) 2017-07-12 2024-06-28 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 지방독성 손상을 저감하기 위한 화합물
WO2021072773A1 (zh) * 2019-10-18 2021-04-22 山东新时代药业有限公司 一种奥利司他胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
EP1028115B1 (en) * 1999-01-29 2002-11-20 F. Hoffmann-La Roche Ag Purification of lipstatin
CN100423715C (zh) * 2000-07-28 2008-10-08 霍夫曼-拉罗奇有限公司 新型药物组合物
CA2417607C (en) * 2000-08-09 2008-01-29 Christine Feinle Lipase inhibitors for the treatment of dyspepsia
IL162323A0 (en) * 2001-12-04 2005-11-20 Biogal Pharmaceutical Co Preparation of orlistat and orlistat crystalline forms
ES2329474T3 (es) * 2003-09-12 2009-11-26 Ranbaxy Laboratories Limited Proceso para la preparacion de formas cristalinas del orlistat.
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat

Also Published As

Publication number Publication date
WO2007073937A3 (en) 2007-08-23
EP1973893A2 (en) 2008-10-01
EA200801573A1 (ru) 2008-10-30
EP1973893B1 (en) 2015-04-29
WO2007073937A2 (en) 2007-07-05
EP1803714A1 (en) 2007-07-04
NO20083269L (no) 2008-09-19
EA015940B1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
IL187586A0 (en) Method for producing dihydroquinazolines
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
MY150538A (en) Process for the manufacture of dihydropteridinones
WO2009039307A3 (en) Hydrogels and methods for producing and using the same
WO2006136357A3 (de) Kristalline modifikationen des pyraclostrobins
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
EP1908749A4 (en) PROCESS FOR PREPARING ISOCYANATE, ISOCYANATE MADE ACCORDING TO IT AND USE OF ISOCYANATE
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
MX2007011668A (es) Mezclas de caucho de silicona de reticulacion por adicion autoadhesivas, metodo para la produccion de las mismas, metodo para producir partes moldeadas compuestas y uso de las mismas.
MY158910A (en) Surface modified silicic acid semi-gels
IL180551A0 (en) Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
EG25069A (en) Process for urea production and related plant.
MX2009008422A (es) Proceso para la preparacion de alquilpiridinas de 5-(1-alquiltio)2-sustituidas.
TW200732410A (en) Sprayable acoustic compositions
WO2007141593A3 (en) Process for the preparation of metoprolol and its salts
NO20083269L (no) Prosess for a anvende krystallinsk orlistatmetoder
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
EG24992A (en) Process for urea production and related plant.
EG25292A (en) Process for the production of anilines.
TW200730521A (en) Triazine compounds having amino-and carboxyl-containing substituents
MY146610A (en) Process of producing bleach boosters
TW200637832A (en) Process for preparing amorphous valsartan